When my AMH came back at 0.9 last year, I froze. The doctor said natural conception was very unlikely and told me to move straight to assisted reproduction. For weeks I saved folders on Greece surrogacy, IVF vs Wuhan IVF Success Rates’>Georgia IVF, the US and Ukraine, then spent three months second-guessing every option. I am writing this down for the version of me who needed one honest story. Low AMH is scary, but panic makes expensive mistakes. I did not have a perfect plan; I had a process, and that process is what finally made my choice feel less like gambling.
If Your AMH Is Low, Do Not Pick a Country First
The real trap with low AMH is not that there are fewer eggs. It is that fear pushes people into a contract before they understand their own ovaries. I know a woman whose AMH was 1.1. She signed a surrogacy agreement before anyone had even decided her stimulation protocol. Her first retrieval produced four eggs and none became blastocysts. So before I compared borders, I forced myself to answer three things. First, could my ovaries still collect enough usable eggs? I tracked antral follicles for three months: four, then five, then four. The doctor guessed one retrieval might give only three to five eggs. Second, could I accept multiple egg retrievals to bank embryos? That takes time, money and a body that can keep showing up. Third, what was my absolute ceiling? Once those answers were clear, countries stopped feeling like a blur. If your AMH is under 1, do not build a plan on one blood draw. AMH can swing by 0.3 or more; use serial monitoring and repeat what matters.
Greece Surrogacy vs Georgia IVF: Birth Certificates Changed My Math
Most people compare these two routes by price alone, and I get it. In Greece, a surrogacy cycle plus surrogate compensation often lands around 550,000 to 700,000 RMB. In Georgia, if you carry the pregnancy yourself, medical costs can fit inside 200,000 to 300,000 RMB. But the detail that kept me up was not the clinic fee; it was the paper the baby would be born with. In Greece, surrogacy practice is more mature, yet there are still lawyer costs and specific steps around how the surrogate is recorded and how intended parentage is established. I was told to budget another 20,000 to 30,000 RMB just for legal navigation. In Georgia, commercial surrogacy is legal, and after birth the birth certificate can directly name the intended parents without waiting for the surrogate to surrender rights. That can shorten the timeline by one to two months. A couple I know finished the whole Georgian surrogacy path from signing to certificate in fourteen months. Paperwork is boring until it becomes the only thing that matters.
AMH 0.9 and the Doctor Who Told Me to Try Carrying First
This part surprised me. I assumed my AMH meant surrogacy was the only road left. The clinic counselor instead walked me through the numbers like a strategist. At 38 with AMH 0.9, using donor eggs could push success above 60 percent, but I did not want another woman’s eggs. If I insisted on my own, the bottleneck was embryo quality, not geography. Her advice was almost insultingly simple: run one mild stimulation cycle and see what my eggs can actually do. No grand theory, just data. I retrieved five eggs, four fertilized, two reached blastocyst stage, and one passed screening. That is not a glamorous report, but it was enough to make hope rational. Later I learned something that saved me from despair: low AMH often means low quantity, not automatically poor quality. One euploid embryo is a real starting point, and for me it changed the route from fear to planning.
I Signed in Georgia, but Three Contract Lines Held Me for Two Days
In the end I signed for a hybrid Georgia plan: create embryos at a local clinic first, then match with a surrogate. The market there is often more than 50 percent cheaper than the US, and I kept the total budget near 550,000 RMB. But the morning I signed, three lines kept pulling my eyes back. First, if no embryo passed screening, would the surrogate match be postponed, and how would fees be recalculated? Second, if the surrogate developed pregnancy complications, who carried medical responsibility and up to what limit? Third, if birth registration hit a delay after delivery, what exactly was the agency obligated to do, in writing, not in a smile? Each line matched a risk I had heard about in real cases. For surrogate screening, I did not worship a file; I looked at obstetric history and endometrium thickness like a skeptic. Good agencies answer these questions quickly. Slow answers are also an answer.
My conclusion is not that Georgia is always right or Greece is wrong. It is that low AMH families should sequence decisions: measure the ovaries, price the legal paperwork, test embryo quality early, then read every contract line that touches delays, complications and birth registration. For me, Georgia won because the certificate path was clearer and the budget matched reality, while my own body still deserved one honest trial. If you are stuck between countries, stop asking which flag looks friendlier. Ask which system gives your future child the fastest, cleanest legal identity, and which plan your ovaries can actually survive.